UK-based international specialty pharmaceutical company, Martindale pharma has announced the appointment of AFT Pharmaceuticals as its distribution partner for Asia Pacific markets.
This agreement with AFT forms part of Martindale Pharma’s strategy to expand its international business towards countries committed to expanding healthcare provision and spend on medicines.
Under the deal inked by both the companies, AFT will be responsible for the registration, distribution, promotion and marketing of certain Martindale Pharma’s products in Malaysia, Singapore and Brunei. AFT has a significant presence in Asia Pacific and operates across New Zealand, Australia, Malaysia, Hong Kong, Singapore and Brunei.
Mr Mike Harris, CEO, Martindale Pharma, commented, “The demand for Critical Care and Hospital Specialty products in these markets is growing rapidly. Martindale Pharma’s strategy is to partner with companies that have a strong presence in key international markets. We look forward to working with AFT Pharmaceuticals to distribute and promote world-class products to patients and hospitals in Malaysia, Singapore and Brunei.”
“We are pleased to have partnered with Martindale Pharma,” said, Dr Hartley Atkinson, Managing Director of AFT Pharmaceuticals. “We look forward to providing our expertise in delivering high quality products to hospitals, and patients across different countries in Asia Pacific.”
Source: BioSpectrum
